Virginia Retirement Systems’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.3M Sell
267,461
-22,750
-8% -$4.89M 0.4% 55
2026
Q1
$63.1M Sell
290,211
-34,900
-11% -$7.74M 0.47% 54
2025
Q4
$74.3M Buy
325,111
+32,000
+11% +$7.29M 0.44% 47
2025
Q3
$67.9M Buy
293,111
+96,200
+49% +$19.6M 0.44% 52
2025
Q2
$36.6M Sell
196,911
-137,500
-41% -$25.6M 0.25% 111
2025
Q1
$70.1M Buy
+334,411
New +$65M 0.52% 45
2023
Q3
$25.1M Sell
168,411
-21,900
-12% -$3.21M 0.25% 129
2023
Q2
$25.6M Sell
190,311
-3,800
-2% -$557K 0.25% 125
2023
Q1
$30.9M Sell
194,111
-179,942
-48% -$27.5M 0.32% 96
2022
Q4
$60.5M Sell
374,053
-26,400
-7% -$4.05M 0.63% 32
2022
Q3
$53.7M Buy
+400,453
New +$57.5M 0.61% 33
2022
Q1
$65.2M Hold
401,953
– – 0.61% 28
2021
Q4
$54.4M Hold
401,953
– – 0.37% 56
2021
Q3
$43.4M Buy
401,953
+157,300
+64% +$18M 0.44% 53
2021
Q2
$27.6M Sell
244,653
-800
-0.3% -$90.1K 0.27% 89
2021
Q1
$26.6M Sell
245,453
-34,800
-12% -$3.72M 0.26% 92
2020
Q4
$30M Sell
280,253
-92,600
-25% -$8.9M 0.32% 82
2020
Q3
$32.7M Sell
372,853
-77,700
-17% -$7.32M 0.37% 69
2020
Q2
$44.2M Buy
450,553
+1,853
+0.4% +$163K 0.52% 43
2020
Q1
$34.2M Sell
448,700
-26,800
-6% -$2.28M 0.47% 44
2019
Q4
$42.1M Sell
475,500
-27,300
-5% -$2.27M 0.45% 49
2019
Q3
$38.1M Buy
502,800
+54,800
+12% +$3.76M 0.43% 53
2019
Q2
$32.6M Buy
448,000
+86,500
+24% +$6.8M 0.37% 62
2019
Q1
$29.1M Buy
361,500
+28,300
+8% +$2.32M 0.34% 75
2018
Q4
$30.7M Sell
333,200
-101,800
-23% -$8.95M 0.42% 57
2018
Q3
$41.1M Hold
435,000
– – 0.48% 40
2018
Q2
$40.3M Buy
435,000
+27,400
+7% +$2.68M 0.49% 43
2018
Q1
$38.6M Hold
407,600
– – 0.47% 42
2017
Q4
$39.4M Buy
407,600
+44,700
+12% +$4.21M 0.47% 43
2017
Q3
$32.2M Sell
362,900
-160,800
-31% -$12.2M 0.39% 55
2017
Q2
$38M Buy
523,700
+192,000
+58% +$12.9M 0.48% 39
2017
Q1
$21.6M Buy
331,700
+180,600
+120% +$11.4M 0.28% 97
2016
Q4
$9.46M Sell
151,100
-5,900
-4% -$360K 0.13% 211
2016
Q3
$9.9M Hold
157,000
– – 0.14% 195
2016
Q2
$9.72M Buy
+157,000
New +$9.57M 0.14% 192
2015
Q4
$15.9M Sell
268,194
-1,733
-0.6% -$99.8K 0.24% 120
2015
Q3
$14.7M Sell
269,927
-33,037
-11% -$2.15M 0.23% 131
2015
Q2
$20.4M Buy
302,964
+18,373
+6% +$1.2M 0.31% 93
2015
Q1
$16.7M Sell
284,591
-151,566
-35% -$9.16M 0.25% 128
2014
Q4
$28.5M Buy
436,157
+49
+0% +$3.09K 0.45% 54
2014
Q3
$25.2M Buy
436,108
+66,725
+18% +$3.7M 0.42% 62
2014
Q2
$20.8M Buy
369,383
+135,723
+58% +$7.12M 0.36% 69
2014
Q1
$12M Sell
233,660
-148,284
-39% -$7.49M 0.23% 138
2013
Q4
$20.2M Buy
381,944
+4,821
+1% +$237K 0.4% 63
2013
Q3
$16.9M Sell
377,123
-592,366
-61% -$26.3M 0.36% 79
2013
Q2
$40.1M Buy
+969,489
New +$42.4M 0.75% 31

Other funds holding ABBV

Virginia Retirement Systems's ABBV Position: Q2 2026 in Review

Virginia Retirement Systems reduced its AbbVie (ABBV) stake by 7.8% in Q2 2026, selling an estimated $4.89M and leaving 267,461 shares worth $67.3M. The position accounts for 0.4% of the portfolio, ranked #55.

Virginia Retirement Systems first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. The position peaked at $74.3M in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Virginia Retirement Systems held 267,461 shares of AbbVie worth $67.3M as of Q2 2026.
  • Virginia Retirement Systems sold 22,750 AbbVie shares in Q2 2026, an estimated $4.89M.
  • AbbVie made up 0.4% of Virginia Retirement Systems's portfolio in Q2 2026, its #55 holding.
  • Virginia Retirement Systems first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
  • Virginia Retirement Systems's AbbVie position peaked at $74.3M in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.